Ceera Investments LLC Has $4.15 Million Stake in CME Group Inc. $CME

Posted by Brian Himes on May 26th, 2026

Ceera Investments LLC lowered its position in CME Group Inc. (NASDAQ:CME – Free Report) by 22.4% during the fourth quarter, Holdings Channel reports. The firm owned 15,187 shares of the financial services provider’s stock after selling 4,386 shares during the period. CME Group comprises 1.6% of Ceera Investments LLC’s portfolio, making the stock its 24th largest holding. Ceera Investments LLC’s holdings in CME Group were worth $4,147,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. West Family Investments Inc. lifted its position in shares of CME Group by 1.2% in the 3rd quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after purchasing an additional 37 shares during the period. Asset Dedication LLC lifted its position in shares of CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares during the period. Northwestern Mutual Investment Management Company LLC lifted its position in shares of CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after purchasing an additional 37 shares during the period. Rehmann Capital Advisory Group lifted its position in shares of CME Group by 4.3% in the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after purchasing an additional 37 shares during the period. Finally, Atlatl Advisers LLC lifted its position in shares of CME Group by 1.8% in the 3rd quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock worth $574,000 after purchasing an additional 38 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares in the company, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the sale, the general counsel owned 7,192 shares of the company’s stock, valued at $2,397,597.04. This trade represents a 31.39% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 44,044 shares of company stock worth $13,297,507. 0.30% of the stock is owned by corporate insiders.

CME Group Stock Performance

Shares of CME stock opened at $291.23 on Tuesday. The firm has a market capitalization of $105.53 billion, a PE ratio of 24.85, a price-to-earnings-growth ratio of 3.52 and a beta of 0.23. The firm has a fifty day simple moving average of $295.98 and a two-hundred day simple moving average of $289.46. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12 month low of $257.17 and a 12 month high of $329.16.

CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The business had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. CME Group’s quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.80 EPS. Analysts forecast that CME Group Inc. will post 12.28 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Tuesday, June 9th. CME Group’s payout ratio is 44.37%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on CME shares. Barclays lowered their price objective on shares of CME Group from $343.00 to $316.00 and set an “equal weight” rating for the company in a research note on Thursday, April 23rd. UBS Group reiterated a “neutral” rating and issued a $310.00 price objective on shares of CME Group in a research note on Friday, February 6th. Wall Street Zen lowered shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, April 26th. Jefferies Financial Group lowered their price objective on shares of CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research note on Thursday, April 9th. Finally, Erste Group Bank upgraded shares of CME Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, March 5th. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $305.29.

Read Our Latest Research Report on CME Group

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.